13-15 September 2023
Join us at EPUAP 2023 in Leeds
Reducing the burden of pressure ulcers.
It’s possible.
Shape the future of wound care, share your vision and explore the latest evidence at Stand 22.
Reducing the burden of pressure ulcers.
It’s possible.
Shape the future of wound care, share your vision and explore the latest evidence at Stand 22.
We’ll be supporting the EPUAP scientific programme with expert-led sessions on the latest in pressure ulcer prevention and management.
Join us 13th Sept, 13.30 -15:00 in the Bury theatre to hear how experts combine a multidisciplinary approach, an effective protocol and treatment innovation to help optimise clinician time, save money and improve patients’ quality of life.
Join us in making a difference in patient care by participating in the pressure ulcer management survey.
Your expertise and insights are crucial in understanding current practices and challenges surrounding pressure ulcer management. By sharing your experiences, you can help shape better prevention strategies and enhance patient outcomes.
Take the 5 question survey here and get the results of the pressure ulcer survey in your inbox.
Could foam dressing technology help reduce the incidence of pressure ulcers as part of a prevention strategy?1 Evidence has highlighted the potential impact of using of ALLEVYN◊ LIFE Dressings:
Reducing the burden of pressure injuries. It’s possible.
Sometimes, pressure ulcers require a more powerful intervention (particularly for non-healing wounds). With the OneNPWT clinical pathway, discover simplified decision-making for our RENASYS◊ Negative Pressure Wound Therapy System and PICO◊ Single Use Negative Pressure Wound Therapy System.
Simplifying negative pressure wound therapy. It’s possible.
Complete the form to subscribe to our updates. With your insights and expertise, help us shape what’s possible in wound care, use the comment box to share your thoughts, request more information or submit a question to our expert speakers.
*As demonstrated in laboratory testing; p<0.001; compared to Mepilex™ Border and Optifoam™ Gentle; average and peak pressure forces.
**When used as part of a comprehensive prevention program and when compared to standard care alone; p=0.001.
4
For detailed product information, including indications for use, contraindications, precautions and warnings, please consult the product’s applicable Instructions for Use (IFU) prior to use.
Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Smith+Nephew representative or distributor if you have questions about the availability of Smith+Nephew products in your area.
All trademarks acknowledged. ©2023 Smith+Nephew. All rights reserved.